These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1337168)

  • 21. Stability of iron concentrations in peritoneal dialysis solution bags.
    Park SE; Twardowski ZJ; Moore HL
    Perit Dial Int; 1997; 17(2):210-1. PubMed ID: 9159851
    [No Abstract]   [Full Text] [Related]  

  • 22. Reducing the formation of glucose degradation products in peritoneal dialysis solutions by ultrahigh temperature ohmic heating.
    Shapira A; Shazman A; Ungar Y; Shimoni E
    Mol Nutr Food Res; 2007 Apr; 51(4):473-8. PubMed ID: 17390399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM; Davin JC; Lambrechts L; Heynen G
    Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-alpha-hydroxycholecalciferol for renal osteodystrophy.
    Brownjohn AM; Goodwin FJ; Hately W; Marsh FP; O'Riordan JL; Papapoulos SE
    Br Med J; 1977 Sep; 2(6089):721-3. PubMed ID: 912269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 25-hydroxycholecalciferol in the treatment of renal osteodystrophy in haemodialysed patients.
    Coen G; Taccone-Gallucci M; Bonucci E; Bianchini G; Gallucci G; Lucentini G; Matteucci MC; Picca S; Casciani CU
    Int J Artif Organs; 1979 Nov; 2(6):278-81. PubMed ID: 511368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albumin and whole-body protein synthesis respond differently to intraperitoneal and oral amino acids.
    Tjiong HL; Fieren MW; Rietveld T; Wattimena JL; Schierbeek H; Huijmans JG; Hop WC; Swart GR; van den Berg JW
    Kidney Int; 2007 Aug; 72(3):364-9. PubMed ID: 17554255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vitamin D. A comparison of 1 alpha OHD2 and 1 alpha OHD3 in rats.
    Sjödén G
    Acta Orthop Scand Suppl; 1985; 217():1-84. PubMed ID: 3911723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and effectiveness evaluation of a domestic peritoneal dialysis fluid packed in non-PVC bags: study protocol for a randomized controlled trial.
    Zhou J; Cao X; Lin H; Ni Z; He Y; Chen M; Zheng H; Chen X
    Trials; 2015 Dec; 16():592. PubMed ID: 26715594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-Acetylglucosamine- an osmotic slute for peritoneal dialysis without inducing hyperinsulinemia.
    Breborowicz A; Połubińska A; Simon M; Tam P; Wu G
    Blood Purif; 2004; 22(2):183-7. PubMed ID: 15044816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The suitability of 1-alpha-hydroxycholecalciferol for the prevention of recurrent parturient paresis in dairy cows].
    Zepperitz H
    Tierarztl Prax; 1993 Feb; 21(1):19-25. PubMed ID: 8470100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
    Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
    Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of lidocaine hydrochloride in 5% dextrose injection in plastic bags.
    Smith FM; Nuessle NO
    Am J Hosp Pharm; 1981 Nov; 38(11):1745-7. PubMed ID: 7304630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca2+ and glucose concentrations.
    Simonsen O; Venturoli D; Wieslander A; Carlsson O; Rippe B
    Kidney Int; 2003 Jul; 64(1):208-15. PubMed ID: 12787411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis.
    Shin SK; Kamerath CD; Gilson JF; Leypoldt JK
    Nephrol Dial Transplant; 2006 Oct; 21(10):2874-80. PubMed ID: 16877489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal fluid kinetics: comparison between polyglucose solution and albumin solution.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Adv Perit Dial; 1999; 15():21-7. PubMed ID: 10682066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The new peritoneal dialysis solutions: friends only, or foes in part?
    ter Wee PM; van Ittersum FJ
    Nat Clin Pract Nephrol; 2007 Nov; 3(11):604-12. PubMed ID: 17957197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy.
    Watson AR; Kooh SW; Tam CS; Reilly BJ; Balfe JW; Vieth R
    Child Nephrol Urol; 1988-1989; 9(4):220-7. PubMed ID: 3255485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phthalic acid esters in the peritoneal cavity of patients treated with continuous ambulatory peritoneal dialysis].
    Sevela K; Gajdůsková V; Havlát F; Havránková V; Jarosová A
    Vnitr Lek; 1996 Jun; 42(6):404-7. PubMed ID: 8928411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.